BOI:EPA
Boiron SA
€19.80
arrow_downward
-0.25%(-0.050) 1D
Oct 2, 5:35:09 PM GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BOI...
Open
€20.00
High
€20.00
Low
€19.60
Mkt. cap
345.61M
Avg. vol.
3.91K
Volume
5.36K
P/E ratio
13.13
52-wk high
€32.25
52-wk low
€19.55
EPS
€1.51
Shares outstanding
17.55M
No. of employees
3K
Open
€20.00
High
€20.00
Low
€19.60
Mkt. cap
345.61M
Avg. vol.
3.91K
Volume
5.36K
P/E ratio
13.13
52-wk high
€32.25
52-wk low
€19.55
EPS
€1.51
Shares outstanding
17.55M
No. of employees
3K
News stories
From web sources and news partners
24/7 Wall St.
·
10 minutes ago
Fortinet Turned $1,000 Into $24,579 in a Decade While the S&P 500 Delivered $3,585
TradingView
·
44 minutes ago
Earnings Scoreboard: all 8 S&P 500 firms beat EPS estimates, 6 saw profits rise Y/Y
디지털투데이
·
54 minutes ago
Will XRP reach $2? How Evernos Nasdaq listing could affect price
Business Insider
·
6 hours ago
The NYSE's Most Famous Floor Trader Says AI Can't Take His Job
Profile
Boiron is a manufacturer of homeopathic products, headquartered in France and with an operating presence in 59 countries worldwide. It is the largest manufacturer of homeopathic products in the world. In 2004, it had a workforce of 2,779 and turnover of € 313 million. It is a member of the CAC Small stock index.
In June 2005, the firm acquired Dolisos Laboratories, then the world's second largest manufacturer of homeopathic preparations.
Products of Boiron include mono- and poly-preparations, which Boiron refer to as "proprietary drugs".
Homeopathy is a pseudoscience with no evidence of effectiveness for stated claims or plausible mechanism of medicinal effect, and several class action lawsuits have been filed on behalf of consumers claiming that Boiron's homeopathic products, including Children's Coldcalm and Oscillococcinum, are useless and Boiron's marketing of these products is deceptive. Wikipedia
About Boiron SA